{"id":45783,"date":"2025-11-04T22:11:22","date_gmt":"2025-11-04T14:11:22","guid":{"rendered":"https:\/\/flcube.com\/?p=45783"},"modified":"2025-11-04T22:11:23","modified_gmt":"2025-11-04T14:11:23","slug":"roche-announces-a-55-m-partnership-with-manifold-bio-to-build-bbb-shuttles","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45783","title":{"rendered":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles"},"content":{"rendered":"\n<p>Swiss\u2011listed pharmaceutical giant Roche (<a href=\"https:\/\/www.google.com\/finance\/quote\/ROG:SWX\">SWX: ROG<\/a>, <a href=\"https:\/\/www.google.com\/finance\/quote\/RHHBY:OTCMKTS\">OTCMKTS: RHHBY<\/a>) confirmed a strategic alliance with platform biotech <strong>Manifold Bio<\/strong> on <strong>November\u202f2025<\/strong>. The collaboration will harness Manifold\u2019s <strong>tissue\u2011targeting shuttle<\/strong> technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-key-deal-highlights\">Key Deal Highlights<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Up\u2011front payment<\/strong><\/td><td>USD\u202f55\u202fmillion<\/td><\/tr><tr><td><strong>Potential milestone value<\/strong><\/td><td>Up to USD\u202f2\u202fbillion<\/td><\/tr><tr><td><strong>Manifold\u2019s role<\/strong><\/td><td>Early discovery and lead in vitro AI screening<\/td><\/tr><tr><td><strong>Roche\u2019s role<\/strong><\/td><td>Preclinical, clinical development, and clinical testing of shuttles combined with Roche payloads<\/td><\/tr><tr><td><strong>Outside license rights<\/strong><\/td><td>Manifold may use the developed shuttles for non\u2011Roche indications<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-how-the-technology-works\">How the Technology Works<\/h3>\n\n\n\n<p>Manifold Bio has engineered an AI\u2011based platform that evaluates candidate molecules <strong>in vivo<\/strong> to pinpoint actionable therapeutic targets. Their <strong>mDesign AI\u2011driven discovery engine<\/strong> will identify BBB shuttles that are then integrated with Roche\u2019s therapeutic payloads\u2014such as trontinemab for Alzheimer\u2019s disease\u2014to accelerate translational progress.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-roche-s-existing-bbb-platform\">Roche\u2019s Existing BBB Platform<\/h3>\n\n\n\n<p>Roche has invested decades in developing BBB shuttles under the <strong>Brainshuttle<\/strong> program. Clinical trials are underway with therapeutics for Alzheimer\u2019s disease, multiple sclerosis, and the most advanced candidate, <strong>trontinemab<\/strong>. The partnership will expand Roche\u2019s shuttle portfolio and potentially broaden CNS drug accessibility on a global scale.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investment-implications\">Investment Implications<\/h2>\n\n\n\n<p>The $55\u202fM upfront and $2\u202fbillion milestone cap could elevate the market positioning of both Roche and Manifold. Should the shuttles prove clinically effective, the partnership may unlock new therapeutic corridors across the central nervous system, impacting a broad array of neurodegenerative diseases.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45786,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4428,940,163,939],"class_list":["post-45783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-manifold-bio","tag-otcmkts-rhhby","tag-roche","tag-swx-rop"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech Manifold Bio on November\u202f2025. The collaboration will harness Manifold\u2019s tissue\u2011targeting shuttle technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45783\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles\" \/>\n<meta property=\"og:description\" content=\"Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech Manifold Bio on November\u202f2025. The collaboration will harness Manifold\u2019s tissue\u2011targeting shuttle technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45783\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-04T14:11:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-04T14:11:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles\",\"datePublished\":\"2025-11-04T14:11:22+00:00\",\"dateModified\":\"2025-11-04T14:11:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783\"},\"wordCount\":279,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0413.webp\",\"keywords\":[\"Manifold Bio\",\"OTCMKTS: RHHBY\",\"Roche\",\"SWX: ROP\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45783#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45783\",\"name\":\"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0413.webp\",\"datePublished\":\"2025-11-04T14:11:22+00:00\",\"dateModified\":\"2025-11-04T14:11:23+00:00\",\"description\":\"Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech Manifold Bio on November\u202f2025. The collaboration will harness Manifold\u2019s tissue\u2011targeting shuttle technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45783\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0413.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/0413.webp\",\"width\":1080,\"height\":608,\"caption\":\"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45783#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles - Insight, China&#039;s Pharmaceutical Industry","description":"Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech Manifold Bio on November\u202f2025. The collaboration will harness Manifold\u2019s tissue\u2011targeting shuttle technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45783","og_locale":"en_US","og_type":"article","og_title":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles","og_description":"Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech Manifold Bio on November\u202f2025. The collaboration will harness Manifold\u2019s tissue\u2011targeting shuttle technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.","og_url":"https:\/\/flcube.com\/?p=45783","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-04T14:11:22+00:00","article_modified_time":"2025-11-04T14:11:23+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45783#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45783"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles","datePublished":"2025-11-04T14:11:22+00:00","dateModified":"2025-11-04T14:11:23+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45783"},"wordCount":279,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45783#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp","keywords":["Manifold Bio","OTCMKTS: RHHBY","Roche","SWX: ROP"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45783#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45783","url":"https:\/\/flcube.com\/?p=45783","name":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45783#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45783#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp","datePublished":"2025-11-04T14:11:22+00:00","dateModified":"2025-11-04T14:11:23+00:00","description":"Swiss\u2011listed pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) confirmed a strategic alliance with platform biotech Manifold Bio on November\u202f2025. The collaboration will harness Manifold\u2019s tissue\u2011targeting shuttle technology and AI\u2011driven in\u2011vivo drug\u2011discovery engine to design next\u2011generation blood\u2011brain barrier (BBB) shuttles for a portfolio of Roche\u2019s neurological and neurodegenerative payloads.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45783#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45783"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45783#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp","width":1080,"height":608,"caption":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45783#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Roche Announces a $55\u202fM Partnership with Manifold Bio to Build BBB Shuttles"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/0413.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45783"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45783\/revisions"}],"predecessor-version":[{"id":45787,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45783\/revisions\/45787"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45786"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}